Patients With Type 2 Diabetes | Clinical Trial

Key information

Conditions

Diabetes Mellitus Type 2 Behavior Body Weight Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetic Angiopathies Diabetic Nephropathies Diabetic Retinopathy Endocrine System Diseases Eye Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Kidney Diseases Male Urogenital Diseases Metabolic Diseases Metabolic Syndrome Motor Activity Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Peripheral Arterial Occlusive Disease 1 Retinal Diseases Signs and Symptoms Urogenital Diseases Urologic Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, Zhongzheng Dist, 100229, Taiwan

Location status: Recruiting

About this study

This study aims to establish both retrospective and prospective cohorts of patients with type 2 diabetes, enabling long-term follow-up of metabolic factors and related complications (such as cardiovascular disease, nephropathy, and neuropathy), as well as changes in nutritional status and physical function (including dietary habits, body composition, and grip strength). The goal is to identify risk factors that influence clinical outcomes and to provide evidence to support individualized treatment and integrated care strategies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults aged 18 or older.
Patients diagnosed with type 2 diabetes (based on medical history, diagnostic code, or use of hypoglycemic medication).
Participants are willing to participate in the study and have signed the consent form.
Participants are able to complete basic assessments (e.g., height, weight, waist circumference, grip strength, body composition, etc.).

Exclusion criteria

Individuals who cannot understand the study content.
Individuals who cannot cooperate with relevant assessments.
Other individuals who are clinically deemed unsuitable for participation by the project leader.

Treatment and study plan

Primary outcomes

Changes in nutritional status and physical function (including dietary habits, body composition, and grip strength)

Time frame: Everytime after physician's appointment(Usually 3 months).

Study contacts

Contact information is provided by the study sponsor or research team.

Chia-Wen Lu, Present Professor

CONTACT

[email protected]

886-2-23123456 ext. 266703

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Cohort Study of Patients With Type 2 Diabetes

Important dates

Study start: 2025
Primary completion: 2028
Study completion: 2028
First posted: Nov 24, 2025
Registry last updated: Mar 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed